Deucravacitinib Clinical Trials
14 recruitingDrug
Phase 34Phase 23
Showing 1–14 of 14 trials
Recruiting
Phase 3
Long-Term Safety Study of Deucravacitinib Versus Ustekinumab in Participants With Psoriasis (PRAGMATYK)
Plaque Psoriasis
Bristol-Myers Squibb3,040 enrolled363 locationsNCT07116967
Recruiting
Phase 3
A Study to Evaluate the Efficacy, Safety, and Drug Levels of Deucravacitinib (BMS-986165) in Adolescent Participants With Moderate to Severe Plaque Psoriasis
Plaque Psoriasis
Bristol-Myers Squibb366 enrolled123 locationsNCT06979453
Recruiting
A Real-world Study to Evaluate the Effectiveness of Deucravacitinib in Adults With Plaque Psoriasis in France (RePhlect)
Psoriasis
Bristol-Myers Squibb350 enrolled48 locationsNCT06701513
Recruiting
Phase 2
Deucravacitinib in the Treatment of Cicatricial Alopecias
Central Centrifugal Cicatricial AlopeciaFrontal Fibrosing Alopecia
Icahn School of Medicine at Mount Sinai20 enrolled1 locationNCT07508488
Recruiting
Phase 3
A Study to Evaluate the Drug Levels, Efficacy, and Safety of Deucravacitinib (BMS-986165) in Pediatric Participants With Juvenile Psoriatic Arthritis
Juvenile Psoriatic Arthritis
Bristol-Myers Squibb60 enrolled47 locationsNCT06869551
Recruiting
Phase 2
Deucravacitinib (BMS-986165) for Pityriasis Rubra Pilaris
Pityriasis Rubra Pilaris
Mayo Clinic12 enrolled1 locationNCT06444399
Recruiting
A Observational Study to Evaluate Deucravacitinib in Patients With Moderate Plaque Psoriasis in China
Plaque Psoriasis
Bristol-Myers Squibb150 enrolled5 locationsNCT06512337
Recruiting
Deucravacitinib for Patients With Moderate/Severe Psoriasis: A Real-Life Experience in Italy
Psoriasis
Bristol-Myers Squibb200 enrolled1 locationNCT07256015
Recruiting
Phase 3
A Study to Evaluate the Drug Levels, Efficacy and Safety of Deucravacitinib in Pediatric Participants With Moderate to Severe Plaque Psoriasis
Plaque Psoriasis
Bristol-Myers Squibb153 enrolled63 locationsNCT04772079
Recruiting
A Study to Assess Deucravacitinib Safety in Pregnancy
Psoriasis (PsO)
Bristol-Myers Squibb900 enrolled1 locationNCT07017699
Recruiting
Phase 2
Vitiligo Treatment by Targeting TYK2 Mediated Responses
Vitiligo, Generalized
Centre Hospitalier Universitaire de Nice128 enrolled5 locationsNCT06327321
Recruiting
Real-World Safety and Effectiveness of Sotyktu (Deucravacitinib) in Patients With Moderate-to-Severe Plaque Psoriasis in Korea
Moderate to Severe Plaque Psoriasis
Bristol-Myers Squibb505 enrolled2 locationsNCT06258668
Recruiting
A Real-world Observational Study to Compare Effectiveness of Deucravacitinib Vs Apremilast in Adults With Plaque Psoriasis
Psoriasis
Bristol-Myers Squibb1,500 enrolled1 locationNCT05744466
Recruiting
A Study of the Comparative Effectiveness of Deucravacitinib in Adults With Plaque Psoriasis in Japan (RePhlect)
Plaque Psoriasis
Bristol-Myers Squibb600 enrolled2 locationsNCT06382987